Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 1c

Context Therapeutics Inc. (NASDAQ: CNTX) reported Q3 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.

You May Also Be Interested In

• Anthropic agrees to $45bn cloud computing deal with Nscale - report
• Meta remains in talks with EU on addictive features
• FDA: issues early alert on Abiomed heart pump controller purge cassette issue